INFECTIMUNE
Live / Registered — Registered (as of 01 Aug 2023)
What this means for you
Registered since 01 Aug 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97137823
- Registration number
- 7128358
- Mark type
- Stylized text
- Filed
- 22 Nov 2021
- Published for opposition
- 18 Oct 2022
- Registered
- 01 Aug 2023
- Attorney of record
- Michael A. Geller
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical research services, namely, the use of cationic lipid nanotechnology to stimulate immune responses for the purpose of identifying and developing pharmaceutical candidates
Owner
- PDS Biotechnology Corporation, Florham Park, NJ, US
- PDS Biotechnology Corporation, Florham Park, NJ, US
- PDS Biotechnology Corporation, Florham Park, NJ, US
Prosecution history
- 01 Aug 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 01 Aug 2023 — REGISTERED-PRINCIPAL REGISTER
- 30 Jun 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 29 Jun 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 07 Jun 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 11 May 2023 — USE AMENDMENT FILED
- 05 Jun 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 11 May 2023 — TEAS STATEMENT OF USE RECEIVED
- 13 Dec 2022 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 18 Oct 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 18 Oct 2022 — PUBLISHED FOR OPPOSITION
- 28 Sept 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 08 Sept 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 01 Sept 2022 — ASSIGNED TO EXAMINER
- 29 Nov 2021 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED